subgroup of
drug)
→
ReceivesAction
→
approved in the u.s.
| Typicality: | 0.404 |
| Saliency: | 0.361 |
| between 2009 | 2 | temporal |
| new drug → be approved in → the u.s. | 5 |
| new drug → be approved in → recent years | 4 |
| new drug → be approved in → the united states | 4 |
| negative | neutral | positive |
| 0.149 | 0.599 | 0.252 |
| Raw frequency | 13 |
| Normalized frequency | 0.361 |
| Modifier score | 0.500 |
| Perplexity | 49.526 |